Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Bullboard Posts
Comment by Nastysaskyon Apr 02, 2019 9:11am
101 Views
Post# 29568592

RE:Financials Tomorrow

RE:Financials Tomorrow
Alba1314 wrote: Wondering what others would conisder a postive vs negative report. Tomorrow will be an important view into how the company's resources are being managed. We know there have been deals/sales made. I wondering what other expectations are for revenue or profit/loss?


I want to see high gross margins, a plan for the roll out of their own retail outlets, and some commentary on margins increasing as the cost of wholesale cannabis declines. As for revenues, they guided (I believe) $85 mil for 15 months, I want to see they're well on their way to beating their expectations.

We all know the price decrease in cannabis will happen, I want LABS to tell the market they'll make more money as it does.
Bullboard Posts